Operating Cash Flow (Statement)

-$23.82M

TTM · Period ending: Jun 30, 2026 · USD

Latest reported-$23.82Mperiod endingJun 30, 2026

LCTX TTM Cash from Operations (-$1.40M → -$23.82M)

TTM operating cash flow (statement)

High-resolution chart · PNG

LCTX operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lineage Cell Therapeutics, Inc. Common Stock Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Jun 30, 2001	-3,839,535
Mar 31, 2001	-4,270,953
Dec 31, 2000	-4,857,030
Sep 30, 2000	-5,293,456
Jun 30, 2000	-4,632,017
Mar 31, 2000	-4,792,827
Dec 31, 1999	-4,394,901
Sep 30, 1999	-4,300,000
Jun 30, 1999	-4,800,000
Mar 31, 1999	-4,600,000
Sep 30, 1998	-4,600,000
Jun 30, 1998	-4,400,000
Mar 31, 1998	-2,900,000
Dec 31, 1997	-2,400,000
Sep 30, 1997	-1,700,000
Jun 30, 1997	-1,300,000
Mar 31, 1997	-2,400,000
Dec 31, 1996	-2,100,000
Sep 30, 1996	-2,100,000
Sep 30, 1995	-2,100,000
Jun 30, 1995	-2,000,000
Mar 31, 1995	-2,200,000
Dec 31, 1994	-2,000,000
Sep 30, 1994	-1,800,000
Jun 30, 1994	-1,600,000
Mar 31, 1994	-1,400,000
Dec 31, 1993	-1,400,000
Sep 30, 1993	-1,300,000
Jun 30, 1993	-1,300,000
Mar 31, 1993	-1,000,000